NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/02/2017
Back to search
Official data from USPTO
NEW YORK CANCER CONSORTIUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/02/2017
Trademark type
Combined
Nice classes
42
Filing date
03/02/2007
Registration date
09/04/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/02/2017
Last transaction
10/02/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
01/01/2004
First use in commerce
01/01/2004
Drawing code
5
Owner type
99
Owner location
BRONX, NY, US
Examiner
SMIGA,HOWARD
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MONTEFIORE MEDICINE ACADEMIC HEALTH SYSTEM, INC.
M. C. (pessoa física)
Representatives
Kathleen A. Rheintgen Husch Blackwell LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical servicesperforming innovative clinical trials and evaluating new agents and new treatment strategies in patients with advanced cancerwith the results being presented at scientific meetings and published in medical literature
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/02/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/02/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
08/29/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/04/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/24/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/10/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/18/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/04/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/31/2014
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/12/2012
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/12/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2012
ES8R
TEAS SECTION 8 RECEIVED
11/01/2012
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
09/04/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/02/2007
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/26/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
07/25/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2007
ALIE
ASSIGNED TO LIE
07/25/2007
PAPER RECEIVED
07/09/2007
CNRT
NON-FINAL ACTION MAILED
06/19/2007
CNRT
NON-FINAL ACTION WRITTEN
06/18/2007
DOCK
ASSIGNED TO EXAMINER
06/18/2007
MAFR
APPLICATION FILING RECEIPT MAILED
03/13/2007
NWAP
NEW APPLICATION ENTERED
03/08/2007
Continuous trademark protection
Get notified about every new filing that threatens NEW YORK CANCER CONSORTIUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.